TradingView
RocketTickers
Aug 16, 2018 4:55 PM
Teva Announce Positive Topline Phase 3 Fasinumab Results
Long
NYSE:TEVA
1D
Teva Pharmaceutical Industries Limited
NYSE
Description
⋅
Aug 16, 2018 4:55 PM
TEVA: Teva Pharmaceutical Industries Ltd.
2018-08-16 07:00:00
Regeneron and Teva Announce Positive Topline Phase 3 Fasinumab Results in Patients with Chronic Pain from Osteoarthritis of the Knee or Hip
Beyond Technical Analysis
More